NAVB logo

NAVB Total Expenses

Annual Total Expenses

$14.12 M
+$2.01 M+16.61%

December 31, 2022


Summary


Performance

NAVB Total Expenses Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherNAVBexpensesmetrics:

Quarterly Total Expenses

$2.13 M
-$296.40 K-12.21%

September 30, 2023


Summary


Performance

NAVB Quarterly Total Expenses Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherNAVBexpensesmetrics:

Total Expenses Formula

Total Expenses = Cost of Goods Sold + Operating Expenses + Non Operating Expenses

NAVB Total Expenses Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+16.6%-12.2%
3 y3 years+28.5%-12.2%
5 y5 years+0.9%-12.2%

NAVB Total Expenses Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-yearat high+16.6%-57.0%at low
5 y5-yearat high+30.4%-57.0%at low
alltimeall time-68.2%+355.4%-94.3%+161.8%

Navidea Biopharmaceuticals Total Expenses History

DateAnnualQuarterly
Sep 2023
-
$2.13 M(-12.2%)
Jun 2023
-
$2.43 M(+0.2%)
Mar 2023
-
$2.42 M(-24.3%)
Dec 2022
$14.12 M(+16.6%)
$3.20 M(-35.5%)
Sep 2022
-
$4.96 M(+69.3%)
Jun 2022
-
$2.93 M(-1.7%)
Mar 2022
-
$2.98 M(-18.2%)
Dec 2021
$12.11 M(+11.8%)
$3.64 M(+49.7%)
Sep 2021
-
$2.43 M(-9.4%)
Jun 2021
-
$2.68 M(-20.0%)
Mar 2021
-
$3.35 M(+16.1%)
Dec 2020
$10.83 M(-1.4%)
$2.89 M(-0.6%)
Sep 2020
-
$2.91 M(+23.7%)
Jun 2020
-
$2.35 M(-12.5%)
Mar 2020
-
$2.69 M(-3.2%)
Dec 2019
$10.99 M(-1.6%)
$2.77 M(-10.2%)
Sep 2019
-
$3.09 M(+14.9%)
Jun 2019
-
$2.69 M(+10.3%)
Mar 2019
-
$2.44 M(+9.0%)
Dec 2018
$11.17 M(-20.1%)
$2.24 M(-40.3%)
Sep 2018
-
$3.74 M(+39.2%)
Jun 2018
-
$2.69 M(+7.6%)
Mar 2018
-
$2.50 M(-29.2%)
Dec 2017
$13.99 M(-7.5%)
$3.53 M(+47.9%)
Sep 2017
-
$2.39 M(-51.6%)
Jun 2017
-
$4.92 M(+56.4%)
Mar 2017
-
$3.15 M(-26.3%)
Dec 2016
$15.12 M(-29.5%)
$4.27 M(+56.2%)
Sep 2016
-
$2.73 M(-19.8%)
Jun 2016
-
$3.41 M(-27.6%)
Mar 2016
-
$4.71 M(-236.4%)
Dec 2015
$21.45 M(-36.7%)
-$3.45 M(-141.6%)
Sep 2015
-
$8.30 M(+24.3%)
Jun 2015
-
$6.68 M(-32.7%)
Mar 2015
-
$9.92 M(+48.7%)
Dec 2014
$33.91 M(-14.3%)
$6.67 M(-12.3%)
Sep 2014
-
$7.61 M(-26.0%)
Jun 2014
-
$10.29 M(+10.3%)
Mar 2014
-
$9.33 M(-31.3%)
Dec 2013
$39.57 M(+41.0%)
$13.59 M(+31.6%)
Sep 2013
-
$10.33 M(+19.3%)
Jun 2013
-
$8.65 M(+23.5%)
Mar 2013
-
$7.00 M(-0.4%)
Dec 2012
$28.07 M(+13.6%)
$7.03 M(-22.4%)
Sep 2012
-
$9.07 M(+66.5%)
Jun 2012
-
$5.45 M(-16.4%)
Mar 2012
-
$6.52 M(-27.9%)
Dec 2011
$24.70 M(+85.8%)
$9.04 M(+34.4%)
Sep 2011
-
$6.73 M(+87.3%)
Jun 2011
-
$3.59 M(-32.7%)
Mar 2011
-
$5.34 M(+50.2%)
Dec 2010
$13.29 M(+17.2%)
$3.55 M(-5.7%)
Sep 2010
-
$3.77 M(+8.7%)
Jun 2010
-
$3.47 M(-21.5%)
Mar 2010
-
$4.42 M(+54.2%)
Dec 2009
$11.34 M(+12.3%)
$2.86 M(-1.6%)
Sep 2009
-
$2.91 M(+8.6%)
Jun 2009
-
$2.68 M(-7.1%)
Mar 2009
-
$2.89 M(+46.3%)
Dec 2008
$10.10 M
$1.97 M(-40.5%)
Sep 2008
-
$3.32 M(+22.4%)
Jun 2008
-
$2.71 M(+29.1%)
DateAnnualQuarterly
Mar 2008
-
$2.10 M(-94.4%)
Dec 2007
$44.42 M(+367.0%)
$37.68 M(+1715.9%)
Sep 2007
-
$2.08 M(-6.8%)
Jun 2007
-
$2.23 M(-8.6%)
Mar 2007
-
$2.44 M(-12.8%)
Dec 2006
$9.51 M(-0.5%)
$2.79 M(+21.7%)
Sep 2006
-
$2.30 M(+15.0%)
Jun 2006
-
$2.00 M(-17.6%)
Mar 2006
-
$2.42 M(-0.0%)
Dec 2005
$9.56 M(+20.3%)
$2.42 M(+4.1%)
Sep 2005
-
$2.33 M(-16.1%)
Jun 2005
-
$2.77 M(+36.1%)
Mar 2005
-
$2.04 M(-4.4%)
Dec 2004
$7.95 M(-2.1%)
$2.13 M(+10.6%)
Sep 2004
-
$1.93 M(-1.5%)
Jun 2004
-
$1.96 M(+1.0%)
Mar 2004
-
$1.94 M(-19.7%)
Dec 2003
$8.12 M(+2.3%)
$2.41 M(+37.0%)
Sep 2003
-
$1.76 M(-9.0%)
Jun 2003
-
$1.94 M(-3.8%)
Mar 2003
-
$2.01 M(+7.5%)
Dec 2002
$7.94 M(+3.7%)
$1.87 M(-7.1%)
Sep 2002
-
$2.01 M(-6.3%)
Jun 2002
-
$2.15 M(+12.6%)
Mar 2002
-
$1.91 M(+0.6%)
Dec 2001
$7.66 M(-5.0%)
$1.90 M(+6.3%)
Sep 2001
-
$1.79 M(-16.2%)
Jun 2001
-
$2.13 M(+33.8%)
Mar 2001
-
$1.59 M(-24.7%)
Dec 2000
$8.06 M(-42.5%)
$2.12 M(+11.9%)
Sep 2000
-
$1.89 M(-11.9%)
Jun 2000
-
$2.15 M(+12.3%)
Mar 2000
-
$1.91 M(-36.3%)
Dec 1999
$14.03 M(-59.1%)
-
Jun 1999
-
$3.00 M(-9.1%)
Mar 1999
-
$3.30 M(-76.4%)
Dec 1998
$34.30 M(+5.9%)
$14.00 M(+154.6%)
Sep 1998
-
$5.50 M(-6.8%)
Jun 1998
-
$5.90 M(-28.0%)
Mar 1998
-
$8.20 M(-18.8%)
Dec 1997
$32.39 M(+31.7%)
$10.09 M(+46.3%)
Sep 1997
-
$6.90 M(-21.6%)
Jun 1997
-
$8.80 M(+35.4%)
Mar 1997
-
$6.50 M(-21.7%)
Dec 1996
$24.60 M(+98.4%)
$8.30 M(+16.9%)
Sep 1996
-
$7.10 M(+26.8%)
Jun 1996
-
$5.60 M(+33.3%)
Mar 1996
-
$4.20 M(+16.7%)
Dec 1995
$12.40 M(-2.4%)
$3.60 M(+20.0%)
Sep 1995
-
$3.00 M(0.0%)
Jun 1995
-
$3.00 M(-6.3%)
Mar 1995
-
$3.20 M(-27.3%)
Dec 1994
$12.70 M(+53.0%)
$4.40 M(+41.9%)
Sep 1994
-
$3.10 M(+34.8%)
Jun 1994
-
$2.30 M(-14.8%)
Mar 1994
-
$2.70 M(+8.0%)
Dec 1993
$8.30 M(+167.7%)
$2.50 M(+8.7%)
Sep 1993
-
$2.30 M(+9.5%)
Jun 1993
-
$2.10 M(+50.0%)
Mar 1993
-
$1.40 M(+16.7%)
Dec 1992
$3.10 M
$1.20 M(+33.3%)
Sep 1992
-
$900.00 K

FAQ

  • What is Navidea Biopharmaceuticals annual total expenses?
  • What is the all time high annual total expenses for Navidea Biopharmaceuticals?
  • What is Navidea Biopharmaceuticals annual total expenses year-on-year change?
  • What is Navidea Biopharmaceuticals quarterly total expenses?
  • What is the all time high quarterly total expenses for Navidea Biopharmaceuticals?
  • What is Navidea Biopharmaceuticals quarterly total expenses year-on-year change?

What is Navidea Biopharmaceuticals annual total expenses?

The current annual total expenses of NAVB is $14.12 M

What is the all time high annual total expenses for Navidea Biopharmaceuticals?

Navidea Biopharmaceuticals all-time high annual total expenses is $44.42 M

What is Navidea Biopharmaceuticals annual total expenses year-on-year change?

Over the past year, NAVB annual total expenses has changed by +$2.01 M (+16.61%)

What is Navidea Biopharmaceuticals quarterly total expenses?

The current quarterly total expenses of NAVB is $2.13 M

What is the all time high quarterly total expenses for Navidea Biopharmaceuticals?

Navidea Biopharmaceuticals all-time high quarterly total expenses is $37.68 M

What is Navidea Biopharmaceuticals quarterly total expenses year-on-year change?

Over the past year, NAVB quarterly total expenses has changed by -$296.40 K (-12.21%)